Fortis Healthcare Limited has released its disclosure report for the financial year ended March 31, 2026. The announcement provides comprehensive details regarding the listing of corporate bonds on the BSE, including updated ISINs and credit rating upgrades. Furthermore, the company confirms the successful and timely payment of annual interest for its outstanding debt securities, maintaining its commitment to meeting financial obligations for all listed non-convertible instruments.
Listing and Issuance Overview
The company has provided transparency on its corporate bond issuance, which was listed on the BSE on December 19, 2024. The total issuance comprises three major tranches with individual volumes of 500 crore, 500 crore, and 550 crore respectively. Each of these tranches has undergone an update to its ISIN to reflect current holdings.
Credit Rating Upgrades
A significant highlight of the recent financial review is the credit rating upgrade for the company’s debt instruments. As of September 1, 2025, CRISIL upgraded the credit rating for these securities from AA to AA+ with a Stable outlook. This reflects the company’s improved financial standing and robust credit profile, with the verification of these ratings formally completed by December 16, 2025.
Interest Payment Confirmation
Fortis Healthcare successfully met its annual interest payment obligations for all three bond tranches on December 22, 2025. The total interest amounts disbursed were INR 406,398,027, INR 427,787,397, and INR 470,566,137 respectively. The company has confirmed that there were no delays or defaults in servicing these debt securities, ensuring full compliance with the scheduled interest payment dates.
Source: BSE
